- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
New Drug Delivery Method Targets Gut, Reduces IBD Medication Doses by Up to 10 Times- Study - Video
|
Overview
A new drug delivery technique, GlycoCaging, could transform the treatment of inflammatory bowel disease (IBD), allowing medication to be delivered directly to the gut at much lower doses. The proof-of-concept study, published in Science, demonstrates that this method can effectively target the lower gut in mice, using up to 10 times less medication than current therapies.
GlycoCaging works by chemically bonding a drug, such as a steroid, to a molecule found in fruits and vegetables. This molecule can only be broken down by specific bacteria in the gut. Once the drug reaches the lower intestine, the bacteria break the bond, releasing the medication where it's needed.
"With this technique, we have the ability to deliver not just steroids, but a range of drugs including antimicrobial compounds directly to the gut, potentially helping people with inflammatory bowel disease, gut infections and more," said Dr. Harry Brumer, co-senior author and professor in UBC’s department of chemistry.
In trials involving mice with IBD, GlycoCaged steroids were equally effective as high-dose treatments but resulted in much lower drug levels in the rest of the body, reducing potential side effects.
The team found the necessary bacteria in fecal samples from 33 individuals, both with and without IBD, indicating that the system may work in humans. With a patent secured, the researchers are now seeking funding for advanced preclinical and human clinical trials.
Reference: Ma, W. J., et al. (2025). Bespoke plant glycoconjugates for gut microbiota-mediated drug targeting. Science. doi.org/10.1126/science.adk7633.
Speakers
Dr. Garima Soni
BDS, MDS(orthodontics)
Dr. Garima Soni holds a BDS (Bachelor of Dental Surgery) from Government Dental College, Raipur, Chhattisgarh, and an MDS (Master of Dental Surgery) specializing in Orthodontics and Dentofacial Orthopedics from Maitri College of Dentistry and Research Centre. At medical dialogues she focuses on dental news and dental and medical fact checks against medical/dental mis/disinformation